Full text is available at the source.
Latest progress in gene therapy trials for eye diseases
Updated
Abstract
Clinical trials are investigating gene therapy approaches for retinal degenerative diseases, which contribute significantly to vision loss globally.
- Inherited and complex retinal diseases, like retinitis pigmentosa and glaucoma, have substantial genetic diversity and complicated mechanisms.
- Current treatments for these conditions are limited, lacking safe and effective disease-modifying options.
- Various ongoing clinical trials are exploring gene-specific and gene-agnostic therapies, including the use of viral vectors for gene delivery.
- Different delivery methods, such as subretinal and intravitreal, are being tested for their effectiveness in treating these eye diseases.
- Initial results from clinical trials indicate potential benefits of gene therapy, though long-term data is needed to fully evaluate efficacy and safety.
Simplified